Results 61 to 70 of about 65,591 (217)

Metabolic Syndrome and Atrial Cardiomyopathy on the Risk of Stroke Mortality in the General Population

Annals of Noninvasive Electrocardiology, Volume 31, Issue 1, January 2026.
Metabolic syndrome and atrial cardiomyopathy each show a positive but statistically non‐significant association with stroke mortality, but their coexistence confers a synergistically higher risk. ABSTRACT Introduction Metabolic syndrome (MetS) and atrial cardiomyopathy (AtCM) are recognized as risk factors for cardiovascular disease, including stroke ...
Yaodongqin Xia, Xuan Lu, Minglong Chen, Mingfang Li   +3 more
wiley   +1 more source

DDR1 Regulates Femoral Arterial Calcification in Lower‐Extremity Artery Disease Through NF‐Kappa B Activation

Acta Physiologica, Volume 242, Issue 1, January 2026.
ABSTRACT Aim Lower‐extremity arterial disease (LEAD) is a manifestation of atherosclerotic cardiovascular disease, affecting 230 million people worldwide with increasing prevalence. Medial arterial calcification (MAC) is common in LEAD patients and contributes to disease‐related mortality.
Manovriti Thakur, Thibaut Quillard, Nico Angliker, Mark Siegrist, Yvonne Jansen, Yi Yan, Julia Wollenhaupt, Claudia Goettsch, Lars Maegdefessel, Nadia Sachs, Marc Schindewolf, Drosos Kotelis, Heidi Noels, Yvonne Döring   +13 more
wiley   +1 more source

Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double‐blind, placebo‐controlled, phase 3 trial (SYNCHRONIZE™‐1)

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 337-346, January 2026.
Abstract Aims Survodutide, a novel glucagon receptor and glucagon‐like peptide‐1 (GLP‐1) receptor dual agonist, elicited significant weight loss in a phase 2 trial in individuals with obesity without type 2 diabetes (T2D). Two multinational phase 3 trials are investigating survodutide for obesity management in individuals with or without T2D. We report
Carel W. le Roux, Sean Wharton, Biykem Bozkurt, Elke Platz, Gabriele Bleckert, Samina Ajaz Hussain, Martina Brueckmann, Elena Startseva, Isabel M. Kloer, Lee M. Kaplan   +9 more
wiley   +1 more source

Decreased level of serum carnitine might lead to arteriosclerosis progression via the accumulation of advanced glycation end products in maintenance hemodialysis patients

Renal Replacement Therapy, 2017
Background Carnitine is reported to improve insulin resistance and reduce oxidative stress. Hyperglycemia and increased oxidative stress are well known to promote the production of advanced glycation end products (AGEs) that can lead to arteriosclerosis ...
Yumi Kamada, Takashi Masuda, Kazuhiko Kotani, Shinya Tanaka, Takeshi Nakamura, Nobuaki Hamazaki, Yoko Itoh, Ibuki Moriguchi, Naoyuki Kobayashi, Michihito Okubo, Kazuhiro Takeuchi, Shokichi Naito, Yasuo Takeuchi   +12 more
doaj   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha   +8 more
wiley   +1 more source

ARTERIOSCLEROSIS. [PDF]

Journal of the American Medical Association, 1908
The subject of arteriosclerosis has received much attention of late, both in its pathologic and in its clinical aspects. There has been a growing tendency to attribute symptoms, particularly nervous symptoms, to this condition. In a person offering almost any syndrome of symptoms referable to the nervous system, the mere presence of sclerotic arteries
openaire   +1 more source

Circumferential strain and strain rates of the descending aorta as novel measures of aortic stiffness and wall mechanics from standard cardiac MRI

Experimental Physiology, Volume 111, Issue 1, Page 36-42, 1 January 2026.
Abstract During standard cardiovascular magnetic resonance (CMR) the horizontal long‐axis cine image (i.e., 4‐chamber) is captured which includes a cross‐section of the descending aorta. The aortic cross‐section can be used to assess aortic stiffness (distensibility; ∆area/pressure) or circumferential strain (percentage vascular deformation).
Denis J. Wakeham, Sauyeh K. Zamani, Andrew P. Oneglia, Matthew M. Howrey, Samer Majeed, Tiffany L. Brazile, Joshua A. Beckman, James P. MacNamara, Mark J. Haykowsky, Vlad G. Zaha, Benjamin D. Levine, Christopher M. Hearon Jr, Satyam Sarma, Michael D. Nelson   +13 more
wiley   +1 more source

Association between Plasma Adipocytokines Levels and Intracranial versus Extracranial Atherosclerotic among Chinese Patients with Stroke

Iranian Journal of Public Health, 2020
Background: To detect the levels of plasma Adipocytokines, TNF-α, IL-6 and PAI-1 in patients with intracranial and extracranial arteriosclerosis. Methods: From September 2015 to September 2017, 318 patients aged ≥60 years were enrolled.
Chunyu LIU, Xiaodan YANG, Changqing CHEN
doaj  

Arteriosclerosis, Thrombosis, and Vascular Biology , 2005 [PDF]

, 2005
Donald D. Heistad
openalex   +1 more source

EXPERIMENTAL ARTERIOSCLEROSIS [PDF]

Journal of Experimental Medicine, 1904
R M, Pearce, E M, Stanton
openaire   +2 more sources